Can my current medical devices interfere with the imaging results? Are there alternative imaging options available that may ...

Abbott stock rose Wednesday after the health care giant narrowly beat Wall Street's third-quarter expectations and raised the midpoint of its earnings outlook. Please watch the video at Investors ...

Sales growth in the medical devices segment drove Abbott Laboratories’ expectations-beating revenue in the past financial quarter as the company faces lower demand for COVID-19 tests ...

The company's medical devices unit generated $4.75 billion in sales for the third quarter, above analysts' average estimate of $4.68 billion, according to data compiled by LSEG. Overall ...

Abbott Laboratories beat third-quarter profit and sales estimates on strong demand for its medical devices. Sales were also higher at its pharmaceutical unit, but fell at its diagnostics and ...

https://www.tipranks.com/news/the-fly/abbott-reports-q3-worldwide-medical-devices-sales-up-11-7-on-reported-basis Worldwide Medical Devices sales increased 11.7% on a ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals, leading to raised full-year EPS guidance. Despite ongoing NEC baby formula lawsuits ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories narrowed its full-year profit ...

The Sydney Marathon is now an Abbott World Marathon Major, joining the ranks of elite marathons in Boston, London, New York, ...

As Abbott Laboratories prepares to build a plant and bring 450 jobs to Bowling Green, company officials asked for permission to have more fencing and less greenery than required by city zoning. On ...

Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.